InvestorsHub Logo
icon url

Inoviorulez

04/20/16 6:34 PM

#1577 RE: Amatuer17 #1576

It will be nice to get a PR on this, but I don't think the PR about a date for data will move the share price much. It's the actual data to be released for phase 3 results that will move the share price.

Plus we got many catalysts coming up anyways:

Orphan drug status for GvHD
Compassionate use acceptance by FDA
phase 2b data at conference in June

and many others.